ArticleCureus2026
Atypical Ulcerated Cutaneous Presentation of Diffuse Large B-Cell Lymphoma: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diffuse large B-cell lymphoma (DLBCL) is an aggressive malignancy that typically presents with nodal disease, while cutaneous involvement is uncommon and may lead to delayed diagnosis. We report the case of a 48-year-old man presenting with a rapidly enlarging ulcerated mass on the shoulder, complicated by hemorrhage and severe anemia. The lesion had progressed over six months and was associated with significant unintentional weight loss. Imaging revealed a necrotic soft tissue mass, and histopathological examination confirmed diffuse large B-cell lymphoma, centroblastic subtype, with a high proliferative index (Ki-67 70-80%). The patient's clinical course was rapidly progressive, and he died before complete staging, including positron emission tomography (PET) imaging, could be performed. This case highlights the importance of early biopsy of atypical or rapidly progressive cutaneous lesions, as delayed recognition of extranodal presentations of aggressive lymphomas may adversely impact patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.